ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4648
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,204.97
0.30%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. IDEAYA Biosciences Inc (IDYA)

  7. IDEAYA Biosciences Inc (IDYA) Noticias

IDYA IDEAYA Biosciences Inc

38.11
-0.82 (-2.11%)
14 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
IDEAYA Biosciences Inc IDYA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.82 -2.11% 38.11 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
38.41 37.82 38.86 38.11 38.93
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/6/202405:05EDGAR2Form 8-K - Current report
03/6/202405:00PRNUSIDEAYA Announces Results for Darovasertib Phase 2 IST in..
31/5/202415:54EDGAR2Form 8-K - Current report
31/5/202415:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202405:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
29/5/202416:02EDGAR2Form 144 - Report of proposed sale of securities
29/5/202405:00PRNUSIDEAYA Biosciences to Participate in Upcoming June 2024..
28/5/202405:00PRNUSIDEAYA Biosciences Appoints Daniel A. Simon as Chief..
23/5/202420:21PRNUS/C O R R E C T I O N -- IDEAYA Biosciences, Inc./
23/5/202416:05PRNUSIDEAYA Biosciences Announces Abstract Summary Results of..
07/5/202405:04EDGAR2Form 8-K - Current report
07/5/202405:00PRNUSIDEAYA Biosciences, Inc. Reports First Quarter 2024..
01/5/202405:00PRNUSIDEAYA Biosciences to Participate in Upcoming May 2024..
26/4/202405:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
24/4/202409:05PRNUSIDEAYA Biosciences Announces ASCO 2024 Oral Presentation for..
22/4/202405:00PRNUSIDEAYA Biosciences Announces Selection of Move-Forward Phase..
05/4/202405:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
01/4/202405:00PRNUSIDEAYA Biosciences to Participate in Upcoming April 2024..
12/3/202405:00PRNUSIDEAYA Announces Clinical Collaboration to Evaluate IDE161..
04/3/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202416:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202416:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202405:00PRNUSIDEAYA Biosciences to Participate in Upcoming March 2024..
20/2/202415:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
20/2/202405:07EDGAR2Form 8-K - Current report
20/2/202405:00PRNUSIDEAYA Biosciences, Inc. Reports Fourth Quarter and..
14/2/202405:44EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202418:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202416:56EDGAR2Form 144 - Report of proposed sale of securities
01/2/202405:00PRNUSIDEAYA Biosciences to Participate in Upcoming February 2024..
26/1/202405:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
24/1/202418:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202405:03EDGAR2Form 8-K - Current report
19/1/202416:18EDGAR2Form 8-K - Current report
19/1/202416:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/1/202416:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202405:07EDGAR2Form 8-K - Current report
12/1/202415:24EDGAR2Form 144 - Report of proposed sale of securities
12/1/202405:04EDGAR2Form 8-K - Current report
07/1/202408:00PRNUSIDEAYA Biosciences Announces Participation at the 42nd..
29/12/202305:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
27/12/202315:24EDGAR2Form 144 - Report of proposed sale of securities
19/12/202316:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202316:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202318:09EDGAR2Form 144 - Report of proposed sale of securities
14/12/202318:29EDGAR2Form 144 - Report of proposed sale of securities
11/12/202316:45EDGAR2Form 144 - Report of proposed sale of securities
08/12/202305:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..

Su Consulta Reciente

NASDAQ
IDYA
IDEAYA Biosciences
BIT
P11H95
Bnp Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados